← Browse by Condition
Medical Condition

high risk non muscle invasive bladder cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06567743 Phase 2
Recruiting

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Enrollment
325 pts
Location
United States
Sponsor
CG Oncology, Inc.
View Trial →